Cargando…
A molecular map of mesenchymal tumors
BACKGROUND: Bone and soft tissue tumors represent a diverse group of neoplasms thought to derive from cells of the mesenchyme or neural crest. Histological diagnosis is challenging due to the poor or heterogenous differentiation of many tumors, resulting in uncertainty over prognosis and appropriate...
Autores principales: | Henderson, Stephen R, Guiliano, David, Presneau, Nadege, McLean, Sean, Frow, Richard, Vujovic, Sonja, Anderson, John, Sebire, Neil, Whelan, Jeremy, Athanasou, Nick, Flanagan, Adrienne M, Boshoff, Chris |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1242211/ https://www.ncbi.nlm.nih.gov/pubmed/16168083 http://dx.doi.org/10.1186/gb-2005-6-9-r76 |
Ejemplares similares
-
Post-translational regulation contributes to the loss of LKB1 expression through SIRT1 deacetylase in osteosarcomas
por: Presneau, Nadège, et al.
Publicado: (2017) -
Oncogenic transformation of mesenchymal stem cells decreases Nrf2 expression favoring in vivo tumor growth and poorer survival
por: Funes, Juan M, et al.
Publicado: (2014) -
MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression
por: Presneau, N, et al.
Publicado: (2013) -
Assessment of patient-derived tumour xenografts (PDXs) as a discovery tool for cancer epigenomics
por: Guilhamon, Paul, et al.
Publicado: (2014) -
UK Guidelines for the Management of Bone Sarcomas
por: Grimer, Robert, et al.
Publicado: (2010)